Literature DB >> 1395375

The role of hepatic vein Doppler in diagnosing acute rejection following paediatric liver transplantation.

P D Britton1, D J Lomas, R A Coulden, P Farman, S Revell.   

Abstract

Serial Doppler ultrasound examinations of the hepatic veins were performed on 50 consecutive paediatric liver transplants. Damping of the normally pulsatile signal was observed in 23 of the 32 biopsy-proven episodes of rejection. In 10 episodes, the reduction in hepatic vein pulsatility preceded clinical and biochemical evidence of rejection by up to 36 h. Seven cases had damped signals throughout the post-operative period which precluded assessment by this method. In two patients the hepatic vein signals remained pulsatile despite rejection, one patient having unsuspected tricuspid regurgitation, and the other a stenotic IVC anastomosis. In the 35 liver transplants with normal pulsatility, hepatic vein Doppler proved to be a valuable indicator of acute rejection during the first 2 weeks following transplantation (sensitivity 92%, specificity 100%, positive predictive value 100% and negative predictive value 83%).

Entities:  

Mesh:

Year:  1992        PMID: 1395375     DOI: 10.1016/s0009-9260(05)80002-9

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  3 in total

Review 1.  Pediatric applications of abdominal vascular Doppler imaging: Part I.

Authors:  Brian D Coley
Journal:  Pediatr Radiol       Date:  2004-07-27

2.  Hemodynamic changes on color Doppler flow imaging and intravenous contrast-enhanced ultrasound for assessing transplanted liver and early diagnosis of complications.

Authors:  Daozhong Huang; Yunchao Chen; Kaiyan Li; Qingping Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

3.  Doppler ultrasound values after liver transplantation in children and their association with graft outcomes: a protocol for a systematic review and meta-analysis.

Authors:  Martha M Ruiz; Rashid Alobaidi; Michelle Lisa Noga; Robin Featherstone; James Shapiro; Ravi Bhargava
Journal:  BMJ Open       Date:  2019-12-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.